Funder
The National Key Research & Developmental Program of China
National Natural Science Foundation of China
Shandong medical and health science and technology development project
Young Scholars Program of Shandong University
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Developmental Biology,Obstetrics and Gynecology,Genetics,Reproductive Medicine,General Medicine
Reference32 articles.
1. Bertini V, Valetto A, Baldinotti F, Azzarà A, Cambi F, Toschi B, et al. Blepharophimosis, ptosis, epicanthus inversus syndrome: new report with a 197-kb deletion upstream of FOXL2 and review of the literature. Molecular Syndromology. 2019;10:147–53.
2. Verdin H, De Baere E. Blepharophimosis, ptosis, and epicanthus inversus. University of Washington: GeneReviews; 2015. p. 1–18.
3. Zlotogora J, Sagi M, Cohen T. The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet. 1983;35:1020–7.
4. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet. 2001;27:159–66.
5. Bunyan DJ, Thomas NS. Screening of a large cohort of blepharophimosis, ptosis, and epicanthus inversus syndrome patients reveals a very strong paternal inheritance bias and a wide spectrum of novel FOXL2 mutations. EUR J MED GENET. 2019;62:103668.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献